TauRx's Hydromethylthionine Mesylate (HMTM) Demonstrates Significant Reduction in Neurodegeneration in Alzheimer's Disease (AD) | Business

ABERDEEN, Scotland--(BUSINESS WIRE)--Jul 16, 2023--

Related Keywords

Singapore ,United States ,United Kingdom ,Claude Wischik ,Danielle Thomson ,Henrik Zetterberg ,Rebecca Andersen ,Taurx Pharmaceuticals Ltd ,Queen Square Institute Of Neurology ,Square Institute ,Executive Chairman ,Taurx Pharmaceuticals ,Business Wire ,Business ,